Search

Your search keyword '"JOOS, GUY"' showing total 756 results

Search Constraints

Start Over You searched for: Author "JOOS, GUY" Remove constraint Author: "JOOS, GUY"
756 results on '"JOOS, GUY"'

Search Results

3. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study

9. Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report

10. Patient-centered digital biomarkers for allergic respiratory diseases and asthma:The ARIA-EAACI approach – ARIA-EAACI Task Force Report

11. Correlation of BAL Cell Count and Pulmonary Function Tests in the Era of Antifibrotics: Data From the Belgium-Luxembourg Idiopathic Pulmonary Fibrosis Registry.

12. Patient‐centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA‐EAACI approach

13. Development and validation of an electronic daily control score for asthma (e-DASTHMA):a real-world direct patient data study

17. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

19. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

22. RIPK1 kinase-dependent inflammation and cell death contribute to the pathogenesis of COPD

25. Correlation of Broncho-Alveolar Lavage Cell Count and Pulmonary Function Tests in the Era of Antifibrotics: Data from the Belgium-Luxembourg IPF registry

26. Anti-IL5 therapy is associated with attenuated lung function decline in severe eosinophilic asthma patients from the Belgian Severe Asthma Registry.

27. Correlation of Broncho-Alveolar Lavage Cell Count and Pulmonary Function Tests in the Era of Antifibrotics: Data from the Belgium-Luxembourg IPF registry.

28. ERS statement:A core outcome set for clinical trials evaluating the management of COPD exacerbations

31. Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation

34. Mast Cell Stabilizing Drugs

35. Unravelling the role of miR-223 in the regulation of pollutant-aggravated allergic airway inflammation

36. Inhibiting RIPK1 kinase activity is protective in experimental models of COPD

38. Development and Validation of an Electronic Daily Control Score for Asthma (e-DASTHMA)

40. Respiratory sensitization: Advances in assessing the risk of respiratory inflammation and irritation

42. Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation

44. ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations

49. Digital Health Europe (DHE) Twinning on severe asthma-kick-off meeting report

Catalog

Books, media, physical & digital resources